Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Robust QSAR models using Bayesian regularized neural networks.

F R Burden1, D A Winkler

  • 1CSIRO Division of Molecular Science, Private Bag 10, Clayton South MDC, Clayton, Victoria 3169, Australia.

Journal of Medicinal Chemistry
|August 17, 1999
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Massive in Silico Study of Noble Gas Binding to the Structural Proteome.

Journal of chemical information and modeling·2019
Same author

Modelling and predicting the biological effects of nanomaterials.

SAR and QSAR in environmental research·2014
Same author

Self-organizing circuitry and emergent computation in mouse embryonic stem cells.

Stem cell research·2011
Same author

Investigation into the valence electronic structure of norbornene using electron momentum spectroscopy, Green's function, and density functional theories.

The journal of physical chemistry. A·2006
Same author

Orbital based electronic structural signatures of the guanine keto G-7H/G-9H tautomer pair as studied using dual space analysis.

Biophysical chemistry·2006
Same author

Norbornane: an investigation into its valence electronic structure using electron momentum spectroscopy, and density functional and Green's function theories.

The Journal of chemical physics·2004
Same journal

Library Docking for Cannabinoid-2 Receptor Ligands.

Journal of medicinal chemistry·2026
Same journal

Charting New Territory: Systematic Evaluation of the Drug Potential of <i>N</i>-Trifluoromethyl Amides, Ureas & Carbamates.

Journal of medicinal chemistry·2026
Same journal

Red-Light-Triggered <i>In Vitro</i> and <i>In Vivo</i> Photocatalytic Cancer Therapy with Polypyridyl Os(II) Photocatalysts.

Journal of medicinal chemistry·2026
Same journal

Novel Selenium-Containing Small Molecule PD-L1 Inhibitors: Design, Synthesis, and Evaluation of the Antitumor Activity.

Journal of medicinal chemistry·2026
Same journal

HsClpP-Engaging Selective Mitochondrial Pan-PDK Degraders for Cancer Therapy.

Journal of medicinal chemistry·2026
Same journal

Rational Development of Activatable Prodrugs of the GSTP1 Inhibitor NBDHEX: Turn-On NIR Fluorogenic Drug Delivery with Selective Anticancer Activity.

Journal of medicinal chemistry·2026
See all related articles

Bayesian regularized artificial neural networks (BRANNs) offer solutions for developing robust quantitative structure-activity relationship (QSAR) models. This approach addresses challenges in model selection, validation, and architecture optimization for drug discovery.

Area of Science:

  • Computational Chemistry
  • Cheminformatics
  • Artificial Intelligence in Drug Discovery

Background:

  • Quantitative Structure-Activity Relationship (QSAR) modeling is crucial for predicting compound activity.
  • Traditional QSAR methods face challenges in model selection, robustness, and validation.
  • Optimization of artificial neural network architectures is complex.

Purpose of the Study:

  • To introduce Bayesian regularized artificial neural networks (BRANNs) for QSAR model development.
  • To demonstrate how BRANNs can overcome common QSAR modeling limitations.
  • To illustrate the application of BRANNs in receptor-specific QSAR studies.

Main Methods:

  • Development and application of Bayesian regularized artificial neural networks (BRANNs).

Related Experiment Videos

  • Utilizing BRANNs to address issues of model choice, robustness, and validation set selection.
  • Optimization of neural network architecture within the BRANN framework.

    • Main Results:

    • BRANNs provide a framework for enhanced QSAR model development.
    • The method effectively tackles challenges related to model validation and architecture.
    • Successful application demonstrated for compounds targeting benzodiazepine and muscarinic receptors.

    Conclusions:

    • BRANNs offer a powerful and versatile approach to QSAR modeling.
    • This methodology improves the reliability and efficiency of developing predictive drug models.
    • BRANNs show significant potential for advancing drug discovery research.